Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Dobrzeniecka
Observed name:
Dobrzeniecka, Anna
Institution:
Medical University of Warsaw
Observed institution:
Medical University of Warsaw
ORCID:
0000-0003-1731-2329
Observed ORCID:
0000-0003-1731-2329
OpenAlex ID:
A5057852431
Comparison of clinical severity and epidemiological spectrum between coronavirus disease 2019 and influenza in children
2021
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Scientific Reports
·
30
PDF
Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19—analysis of a paediatric part of Polish register SARSTer
2021
·
Anna Mania
, Maria Pokorska-Śpiewak
, et al.
·
Scandinavian Journal of Infectious Diseases
·
25
Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the PANDAA‐PED study
2023
·
Maria Pokorska‐Śpiewak
, Ewa Talarek
, et al.
·
Liver International
·
21
PDF
Liver Fibrosis Evaluated With Transient Elastography in 35 Children With Chronic Hepatitis C Virus Infection
2020
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
The Pediatric Infectious Disease Journal
·
19
Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project
2021
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
Journal of Clinical Medicine
·
15
PDF
Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants
2023
·
Maria Pokorska-Śpiewak
, Małgorzata Pawłowska
, et al.
·
The Pediatric Infectious Disease Journal
·
9
One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series Report
2021
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
Viruses
·
8
PDF
Health‐related quality of life in patients aged 6–18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir
2023
·
Maria Pokorska‐Śpiewak
, Ewa Talarek
, et al.
·
Liver International
·
7
The Influence of Treatment with Ledipasvir/Sofosbuvir on Growth Parameters in Children and Adolescents with Chronic Hepatitis C
2022
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
Viruses
·
7
PDF
Effective Treatment of Chronic Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir in 2 Teenagers With HIV Coinfection: A Brief Report
2021
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
The Pediatric Infectious Disease Journal
·
6
Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report
2022
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
Infectious Disease Reports
·
5
PDF
To treat or not to treat young children with hepatitis C?––real-life experience
2025
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
European Journal of Pediatrics
·
3
PDF
Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report
2025
·
Ewa Talarek
, Małgorzata Aniszewska
, et al.
·
Pathogens
·
2
PDF
Glecaprevir/pibrentasvir in patients aged 3–17 years with chronic hepatitis C: Real‐life data from the POLAC project
2025
·
Anna Dobrzeniecka
, Ewa Talarek
, et al.
·
Journal of Pediatric Gastroenterology and Nutrition
·
2
PDF
Comparison of Noninvasive Methods for the Evaluation of Liver Fibrosis in Children With Chronic Hepatitis C Virus Infection
2025
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
The Pediatric Infectious Disease Journal
·
2
Eight-week treatment with sofosbuvir/velpatasvir may be effective in curing hepatitis C in children
2024
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
Pediatria Polska
·
2
PDF
The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study
2024
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
The Pediatric Infectious Disease Journal
·
2
Long-term Outcomes of Ledipasvir/sofosbuvir Treatment of Chronic Hepatitis C in Four Teenagers With Significant Liver Fibrosis
2021
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
Research Square
·
2
PDF
The impact of pediatric influenza and COVID-19 hospitalization on parental attitudes toward vaccination
2026
·
Piotr Rzymski
, Barbara Szczepańska
, et al.
·
Human Vaccines & Immunotherapeutics
·
1
PDF
Changes in liver stiffness and steatosis in children after successful treatment with sofosbuvir/velpatasvir: Results of the PANDAA-PED study
2025
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Clinical and Experimental Hepatology
·
1
PDF
THU-403 Liver fibrosis and steatosis in children after effective treatment of chronic hepatitis C using direct acting antivirals
2024
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Journal of Hepatology
·
1
RSV, influenza, and COVID-19 in hospitalized children: A comparative analysis of the 2025/2026 epidemic season in Poland
2026
·
Piotr Rzymski
, Ilona Małecka
, et al.
·
Virology
PDF
Challenges in the Management of Hepatitis B Among Children and Adolescents: A 10-Year Single-Center Experience
2026
·
Anna Dobrzeniecka
, Ewa Talarek
, et al.
·
Microorganisms
The impact of pediatric influenza and COVID-19 hospitalization on parental attitudes toward vaccination
2026
·
Rzymski, Piotr
, Szczepańska, Barbara
, et al.
·
Figshare
Treatment of hepatitis C in children and adolescents: our experience to date, current status, and prospects
2026
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Clinical and Experimental Hepatology
PDF
Show more works
View as search
Works count:
29
Citation count:
170
H-index:
7
I10-index:
5
Year
Topic
Type